TrialCirculation2004

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.

Allen J Taylor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.